Genmab — September 2017

[JørgenVarnæs]

novo og bava fik sænkede anbefalinger - men ellers er der vist ikke noget, der kan forklare det meget sure pharma/biotek marked

[Vitus]

Deler jo rigtig nok, det er ikke nemt at forstå at kursen, men når vi så tit hører at gode nyheder er indregnet i kursen, så er det måske nemmere at forstå !

[Nickstar]

Det lader i hvert fald til at meget er indregnet, så det blir rart når der sker noget der får kursen op i nye højder. Det her er da til at falde i søvn er

[E_L]

Copenhagen, Denmark; September 26, 2017 — Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 23,670 shares as a consequence of the exercise of employee warrants.

[E_L]

overexaggerated price move today for such a small number of warrants

[Nickstar]

Lad os håbe de kommer til fornuft imorgen og køber tilbage

[E_L]

New Ofatumumab trial CLL / SLL: Protocol GELLC-7: Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab https://clinicaltrials.gov/ct2/show/NCT03280160

[E_L]

from 2 weeks ago, but i hadnt seen it yet

[bibob]

You were right about the warrants E L . But not many this time.

[E_L]

no, not many, I can't imagine more selling pressure from that side tomorrow

[bibob]

Access denied | www.fiercebiotech.com used Cloudflare to restrict access | www.fiercebiotech.com | Cloudflare

(www.fiercebiotech.com)

[bibob]

Så blev Trump's sundhedsreform skrottet. http://nyheder.tv2.dk/2017-09-26-tv-2-livecenter

[henrik48]

God morgen fra dejlige Sarajevo

[bibob]

God morgen fra skønne Malaga.

[bibob]

Warrants. https://globenewswire.com/news-release/2017/09/26/1132964/0/en/Capital-Increase-in-Genmab-as-a-Result-of-Employee-Warrant-Exercise.html

[JKY_VH]

God morgen https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=335059007&sourcecode=omxnews

[JKY_VH]

tak Japan

[JKY_VH]

25 mio i milestone tager vi gerne med

[JKY_VH]

$ altså:-)

[JørgenVarnæs]

Perfekt! 120 mio patientbase!